Evidence map›Paper›PMID 10698492›Full record

ArticleOncogene2000

EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes.

R Li, H Pei, D K Watson, T S Papas

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 179 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. STAT3 Interactors as Potential Therapeutic Targets for Cancer Treatment.International journal of molecular sciences · 2018
    Review
  16. Article
  17. Article
  18. Article
  19. ATRX and DAXX: Mechanisms and Mutations.Cold Spring Harbor perspectives in medicine · 2017
    Review
  20. Article

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

R LiCenter for Molecular and Structural Biology, Department of Medicine, Medical University of South Carolina, Charleston 29425, USA.
H Pei
D K Watson
T S Papas
MUSC Hollings Cancer Center · US

Funding

THE ROLE OF FLI1 IN CELLULAR DIFFERENTIATION AND DEVELOPMENTP01CA078582 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI TROJANOWSKA, MARIA · 1998 to 2009
$9.1M
FUNCTIONAL ANALYSIS OF ETS1 PROTEIN ISOTYPESR01CA076231 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI PAPAS, TAKIS S · 1999 to 1999
–
NCI NIH HHS P01CA78582NCI NIH HHS R01CA76231
6 · The paper itself

Abstract

ETS1 is a member of the evolutionarily conserved family of ets genes, which are transcription factors that bind to unique DNA sequences, either alone or by association with other proteins. In this study, we have used the yeast two-hybrid system to identify an ETS1 interacting protein. The ETS1 N-terminal amino acid region was used as bait and an interaction was identified with the Daxx protein, referred to as EAP1 (ETS1 Associated Protein 1)/Daxx. This interactin has been shown to exist in yeast and in vitro. EAP1/Daxx and ETS1 are co-localized in the nucleus of mammalian cells. The region in EAP1/Daxx which specifically binds to ETS1 is located within its carboxy terminal 173 amino acid region. The ETS1 interaction region is located within its N-terminal 139 amino acids and is referred as the Daxx Interaction Domain (DID). The DID appears to be conserved in several other ets family members, as well as in other proteins known to interact with Daxx. The EAP1/Daxx interacts with both isoforms of ETS1, p51-ETS1 and p42-ETS1. Interaction of EAP1/Daxx with ETS1 causes the repression of transcriptional activation of the MMP1 and BCL2 genes. The interaction domains of both ETS1 and EAP1/Daxx are required for this repression and deletion of either domain abolishes this activity.

Indexed as

Gene Expression RegulationIntracellular Signaling Peptides and ProteinsNuclear ProteinsTranscriptional ActivationAdaptor Proteins, Signal TransducingAdenocarcinomaAnimalsBinding SitesCarrier ProteinsChlorocebus aethiopsColonic NeoplasmsCo-Repressor ProteinsCOS CellsGenes, bcl-2Macromolecular SubstancesMolecular ChaperonesAdaptor Proteins, Signal TransducingCarrier ProteinsCo-Repressor ProteinsDAXX protein, humanETS1 protein, humanIntracellular Signaling Peptides and ProteinsMacromolecular SubstancesMolecular ChaperonesNuclear ProteinsProto-Oncogene Protein c-ets-1Proto-Oncogene ProteinsProto-Oncogene Proteins c-etsRecombinant Fusion ProteinsTranscription Factors

Identifiers

PMID10698492
OpenAlexW2038368872

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.